Keymed Biosciences Inc. Share Price
Stocks
2162
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:27 30/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 81.55 HKD | +2.45% |
|
+3.89% | +52.57% |
| Market Cap | 2.05TCr 2.4TCr 305.94Cr 271.73Cr 254.12Cr 231.57Cr 435.97Cr 29TCr 441.96Cr 3.07TCr 1.19TCr 15TCr 1.15TCr 1.12TCr 48TCr | P/E 2026 * |
25.5x | P/E 2027 * | 1,434x |
|---|---|---|---|---|---|
| Enterprise Value | 1.94TCr 2.27TCr 289.21Cr 256.88Cr 240.22Cr 218.91Cr 412.13Cr 28TCr 417.79Cr 2.91TCr 1.12TCr 14TCr 1.09TCr 1.06TCr 46TCr | EV / Sales 2026 * |
11.5x | EV / Sales 2027 * | 9.13x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2162 | Delayed | |
Tradegate
| 64Z | Real-time | |
|
Deutsche Boerse AG
| 64Z | Delayed |
| 1 day | +2.45% | ||
| 1 week | +3.89% | ||
| 1 month | +8.66% | ||
| 3 months | +15.27% | ||
| 6 months | +34.35% | ||
| Current year | +52.57% |
| 1 week | 72.3 |  | 82.4 |
| 1 month | 71 | | 82.4 |
| Current year | 44.66 | | 89.75 |
| 1 year | 44.66 | | 89.75 |
| 3 years | 26.6 | | 89.75 |
| 5 years | 16.9 | | 89.75 |
| 10 years | 16.9 | | 89.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 23/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 03/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 29/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 23/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 03/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 21/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/06/25 | Moonshot Holdings Ltd.
| Other | Company | 2,16,00,000 | 7.7216% | |
| 11/06/25 | Moonshot Holdings Ltd.
| Other | Company | 1,88,00,000 | 6.7206% | |
| 15/09/23 | Moonshot Holdings Ltd.
| Other | Company | 1,14,500 | 0.0409% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.45% | +3.89% | +9.83% | +63.43% | 306.17Cr | |
| +4.16% | -0.36% | +49.37% | +94.17% | 7.45TCr | |
| -0.61% | +0.69% | +36.36% | +82.72% | 6.01TCr | |
| -2.54% | -0.21% | +6.34% | +31.72% | 4.82TCr | |
| -3.02% | -5.20% | +27.94% | +34.47% | 4.43TCr | |
| +0.31% | +3.02% | +348.95% | +686.74% | 4.4TCr | |
| -1.96% | -0.33% | +7.04% | +100.99% | 4.16TCr | |
| +3.32% | +3.49% | +11.18% | +51.23% | 3TCr | |
| +4.77% | +6.16% | +36.77% | +22.78% | 2.93TCr | |
| -4.86% | -10.66% | -26.27% | +328.03% | 2.49TCr | |
| Average | +0.21% | +2.16% | +50.75% | +149.63% | 4TCr | |
| Weighted average by Cap. | +0.20% | +1.85% | +59.61% | +150.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 168.18Cr 196.59Cr 25Cr 22Cr 21Cr 19Cr 36Cr 2.41TCr 36Cr 251.76Cr 97Cr 1.23TCr 94Cr 92Cr 3.95TCr | 214.6Cr 250.84Cr 32Cr 28Cr 27Cr 24Cr 46Cr 3.08TCr 46Cr 321.23Cr 124.35Cr 1.57TCr 120.02Cr 117.42Cr 5.03TCr |
| Net income | 67Cr 79Cr 10Cr 8.9Cr 8.32Cr 7.58Cr 14Cr 964.54Cr 14Cr 100.67Cr 39Cr 491.23Cr 38Cr 37Cr 1.58TCr | -1.42Cr -1.66Cr -21.12L -18.76L -17.54L -15.99L -30.1L -20Cr -30.51L -2.12Cr -82.15L -10Cr -79.29L -77.57L -33Cr |
| Net Debt | -112.3Cr -131.26Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.61TCr -24Cr -168.1Cr -65Cr -820.3Cr -63Cr -61Cr -2.63TCr | -94Cr -109.31Cr -14Cr -12Cr -12Cr -11Cr -20Cr -1.34TCr -20Cr -139.98Cr -54Cr -683.09Cr -52Cr -51Cr -2.19TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | HK$81.55 | +2.45% | 26,30,600 |
| 29/26/29 | HK$79.60 | +8.82% | 42,60,252 |
| 28/26/28 | HK$73.15 | -2.40% | 22,44,500 |
| 25/26/25 | HK$74.95 | +1.22% | 6,00,500 |
| 24/26/24 | HK$74.05 | -5.67% | 13,92,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
Select your edition
All financial news and data tailored to specific country editions
